首页 › 基金 › Acuitas Investments, LLC › BMRN

Acuitas Investments, LLC 对 BMRN 的持仓历史

BIOMARIN PHARMACEUTICAL INC · 医疗保健

Acuitas Investments, LLC 在 Q3 2026 的 13F 申报中披露持有 BMRN(BIOMARIN PHARMACEUTICAL INC)7,000 股,市值约 US$420K,约占其申报组合的 16.46%,在其申报持仓中市值排名第 1 位。 Acuitas Investments, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)7.00K 股
申报持仓市值$420.00K
组合权重16.46%
首次申报Q3 2026
最近变动新进
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

Acuitas Investments, LLC 对 BMRN 的持仓演变

Acuitas Investments, LLC 于 Q3 2026 首次披露 BMRN 持仓:7,000 股(约 US$420K)。

逐季持仓明细

季度股数金额变化
Q3 2026 7.00K $420.00K 新进

关于 BMRN 与 13F 数据

BMRN(BIOMARIN PHARMACEUTICAL INC)属于医疗保健行业。我们追踪的基金中还有 26 只申报持有 BMRN,申报仓位最大的包括:PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), 维京环球投资 (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 BMRN 的基金

查看 BMRN 的全部基金持有人 →

常见问题

How long has Acuitas Investments, LLC held BMRN?

Acuitas Investments, LLC has disclosed BMRN holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Acuitas Investments, LLC's current position in BMRN?

As of Q3 2026, Acuitas Investments, LLC holds 7.00K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $420.00K, representing 16.46% of its reported portfolio and ranking #1.

Has Acuitas Investments, LLC been buying or selling BMRN?

In the latest 13F filing (Q3 2026), Acuitas Investments, LLC newly opened its position in BMRN.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, 维京环球投资, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.